[Edaily Reporter Kim Hyung-il ] Mr. Blue Corporation(207760), a comprehensive content platform company primarily focused on webtoon and web novel services, hit the daily price limit on the first trading day following its stock consolidation and has continued its upward trend for a second consecutive day.
Mr. Blue Corporation CI. (Photo courtesy of Mr. Blue Corporation)
According to MP Doctor on the 3rd, as of 9:36 a.m., Mr. Blue Corporation is trading at 3,065 won, up 570 won (22.85%) from the previous trading day.
Trading in Mr. Blue Corporation shares resumed on the 2nd following a re-listing resulting from a stock split. On the previous day, which was its first trading day, the stock hit the daily price limit as strong buying pressure emerged early in the session. Today, it is continuing its upward trend with gains exceeding 20%, maintaining its strong momentum since the stock split.
Previously, the board of directors of Mr. Blue Corporation approved a 5-for-1 stock consolidation in May. As a result, the par value per share was changed from 100 won to 500 won, and the total number of issued shares was reduced to one-fifth of the pre-consolidation level.
Recent improvements in financial performance have also been evident. Mr. Blue Corporation posted a consolidated operating profit of 600 million won in the first half of this year, returning to profitability compared to the same period last year. Net income also turned positive, reaching 3.7 billion won. Mr. Blue Corporation explained that as the benefits of its merger with its web novel subsidiary, Days Entertainment, began to take full effect, the consolidation of overlapping operations, cost reductions, and operational efficiencies led to improved financial results.
Domestic steel companies are expanding their reach into high-tech industries through corporate venture capital (CVC) investments. This move is intended to address the structural growth limitations the…
SamsungElectroMechanics is projected to post its best-ever earnings this year, with operating profit approaching 2 trillion won. As demand for components used in artificial intelligence (AI) servers s…
AprilBio Co.,Ltd. CI. (Photo courtesy of AprilBio Co.,Ltd.)
AprilBio Co.,Ltd.(397030)has obtained early preclinical data for its dual-target RNA interference (RNAi) candidate. With a single adminis…